ARS Pharmaceuticals Inc (NASDAQ: SPRY) on Friday, plunged -8.73% from the previous trading day, before settling in for the closing price of $11.22. Within the past 52 weeks, SPRY’s price has moved between $6.66 and $18.90.
The company achieved an average annual earnings per share of -2241.67%. With a float of $59.73 million, this company’s outstanding shares have now reached $98.84 million.
ARS Pharmaceuticals Inc (SPRY) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ARS Pharmaceuticals Inc is 39.58%, while institutional ownership is 63.79%. The most recent insider transaction that took place on Nov 13 ’25, was worth 190,050. In this transaction Chief Operating Officer of this company sold 21,828 shares at a rate of $8.71, taking the stock ownership to the 10,789 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Chief Business Officer sold 166,380 for $8.87, making the entire transaction worth $1,476,147. This insider now owns 0 shares in total.
ARS Pharmaceuticals Inc (SPRY) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.51 earnings per share (EPS) for the period topping the consensus outlook (set at -0.12) by 0.63. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2241.67% per share during the next fiscal year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
ARS Pharmaceuticals Inc (SPRY) is currently performing well based on its current performance indicators. A quick ratio of 6.51 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.29 in one year’s time.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
Looking closely at ARS Pharmaceuticals Inc (NASDAQ: SPRY), its last 5-days average volume was 2.02 million, which is a jump from its year-to-date volume of 1.87 million. As of the previous 9 days, the stock’s Stochastic %D was 78.90%.
During the past 100 days, ARS Pharmaceuticals Inc’s (SPRY) raw stochastic average was set at 29.91%, which indicates a significant decrease from 68.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.67 in the past 14 days, which was lower than the 0.69 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.40, while its 200-day Moving Average is $12.82. However, in the short run, ARS Pharmaceuticals Inc’s stock first resistance to watch stands at $10.95. Second resistance stands at $11.65. The third major resistance level sits at $12.02. If the price goes on to break the first support level at $9.88, it is likely to go to the next support level at $9.51. Now, if the price goes above the second support level, the third support stands at $8.81.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Key Stats
Market capitalization of the company is 1.01 billion based on 98,849K outstanding shares. Right now, sales total 89,150 K and income totals 8,000 K. The company made 32,500 K in profit during its latest quarter, and -51,150 K in sales during its previous quarter.
